SAGE's Cookie Policy
Close 

To enhance your experience on our site, SAGE stores cookies on your computer. By continuing you consent to receive cookies.

Learn More

Therapeutic Advances in Hematology

Editor-in-Chief:
Oregon Health and Science University, Portland, OR, USA
Editor:
SAGE Publications Ltd, London, UK
Associate Editors:
Charite - University Medicine Berlin, Berlin, Germany
Dana-Farber Cancer Institute, Boston, MA USA
Stanford Cancer Center, Stanford, CA, USA
M.D. Anderson Cancer Center, Houston, TX, USA
Fred Hutchinson Cancer Research Center, Seattle, WA, USA
Huntsman Cancer Institute, University of Utah, UT, USA
 
 Chemical Abstracts Service (CAS)

Subscription Information:
Institutional Subscription, Combined (Print & E-access) £638.00
Institutional Subscription, E-access £574.00
Institutional Subscription, Print Only £625.00
Individual Subscription, Print Only £80.00

To purchase a non-standard subscription or a back issue, please contact SAGE Customer Services for availability.
subscriptions@sagepub.co.uk +44 (0) 20 7324 8701

Institutional, Single Print Issue £115.00
Individual, Single Print Issue £17.00
Frequency: Published 6 times a year eISSN: 2040-6215 ISSN: 2040-6207
Months of Distribution: January , March , May , July , September , November Current Volume: 4 Current Issue: 2
Other Titles in: Hematology  |  Hematologic Disorders  |  Hepatology

Product Type

All

Subject Areas

All